Here are Friday's biggest analyst calls: SpaceX, Nvidia, Apple, Tesla, Crocs, Microsoft, Robinhood & more

Wall Street commentary was broadly constructive, with multiple upgrades and initiations across software, consumer, fintech, industrials, REITs, and gaming. Notable calls included positive views on Nvidia, Apple, Microsoft, Robinhood, and several housing/infrastructure names, while Nike was downgraded to sector weight on slower-than-expected turnaround progress. The biggest individual price targets included $125 for Robinhood, $300 for Honeywell Aerospace, $180 for Granite, and $31 for James Hardie.

Analysis

The cleanest signal here is not the breadth of upgrades, but the clustering around businesses with either pricing power or self-help catalysts while cyclicals with weakening end-demand are getting cut. That usually marks an early-stage factor rotation: quality growth, cash-flow compounding, and “next-12-month EPS visibility” tend to outperform as analysts chase improved visibility rather than macro beta. The market is implicitly rewarding companies that can raise price, take share, or cut cost without needing a demand inflection.

The most interesting second-order effect is in adjacent winners that are not explicitly called out. If Apple’s pricing actions hold, it validates a broader consumer-electronics margin defense playbook, which should help component and software ecosystems more than hardware peers. Likewise, strength in AMT and COLD suggests investors are starting to pay for duration again, which can spill over into other hard-asset cash-yield names once rate volatility settles; that said, towers remain sensitive to real-rate moves, so any hawkish repricing can quickly compress the multiple.

The more durable upside looks concentrated in names with execution upgrades plus low expectations: Diageo, Crocs, Belden, and American Tower. By contrast, Nike’s downgrade is less about one quarter and more about the market realizing the turnaround may be a multi-year reset rather than a clean reacceleration, which is usually when consensus underestimates how long gross margin and inventory normalization can lag. In gaming and travel, the merger/capacity-optimization stories can work, but they are far more fragile if consumer trade-down or regional demand softens into the fall.

The contrarian view is that AI winners are becoming crowded on the same narrative, while some of the more interesting upside may be in industrial software, specialty chemicals, and consumer self-help where estimates are still too conservative. For biotech, the initiations may create tradable squeezes, but unless there is a near-term data catalyst, the upside is mostly multiple-based and can fade fast. This is a market that will likely reward confirmation over promises over the next 4-8 weeks.

Key Decisions for Investors

• Go long DEO vs short NKE for the next 1-3 months: DEO has a credible self-help path with operating leverage, while NKE looks like a longer-duration turnaround that can keep de-rating if China/EMEA trends stay soft. Risk/reward favors the pair because the right-tail for DEO is multiple recovery, while NKE has limited near-term catalyst support.
• Add to AMT on pullbacks over the next 2-6 weeks, but size modestly: the re-rating can continue if core tenancy growth holds and rate volatility eases. Use a tighter stop if 10-year real yields re-accelerate, because the multiple is the primary risk, not the operating trend.
• Initiate a tactical long CROX into the next earnings window: sentiment is still low enough that a modest DTC recovery can drive an outsized move. Best expressed via stock or call spreads, with upside tied to the market repricing FY26/FY27 estimates rather than multiple expansion alone.
• Trade BDC as a relative-value long against a basket of slower-growth industrials: solutions-led mix shift should support estimate upgrades over the next 2-3 quarters. The key risk is that order-size improvement is overstated and pricing gains fail to offset softer volumes.
• Stay long NVDA/MSFT on any AI pullback, but prefer MSFT for a lower-volatility expression: the market is increasingly distinguishing monetize-now AI from pure expectation premium. NVDA remains the cleaner momentum trade, while MSFT offers better defense if AI capex sentiment cools.